Cargando…
Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
Liquid biopsy represents a minimally invasive procedure that can provide similar information from body fluids to what is usually obtained from a tissue biopsy sample. Its implementation in the clinical setting might significantly renew the field of medical oncology, facilitating the introduction of...
Autores principales: | Saenz-Antoñanzas, Ander, Auzmendi-Iriarte, Jaione, Carrasco-Garcia, Estefania, Moreno-Cugnon, Leire, Ruiz, Irune, Villanua, Jorge, Egaña, Larraitz, Otaegui, David, Samprón, Nicolás, Matheu, Ander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679205/ https://www.ncbi.nlm.nih.gov/pubmed/31284524 http://dx.doi.org/10.3390/cancers11070950 |
Ejemplares similares
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
por: Egaña, Larraitz, et al.
Publicado: (2020) -
Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2020) -
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016) -
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2018) -
Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2022)